Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy.
Saved in:
| Title: | Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy. |
|---|---|
| Authors: | Wang XS; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Srour SA; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Mendoza T; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Whisenant M; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Research, Cizik School of Nursing, The University of Texas Health Science Center at Houston, Houston, Texas, USA., Subbiah I; Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gonzalez E; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kamal M; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Shen SE; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Cleeland C; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rezvani K; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Neelapu S; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ahmed S; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Shpall E; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. |
| Source: | British journal of haematology [Br J Haematol] 2023 May; Vol. 201 (4), pp. 738-746. Date of Electronic Publication: 2023 Feb 02. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2141 |
|---|---|
| DOI: | 10.1111/bjh.18677 |
